BAILLIE GIFFORD & CO - 31 Dec 2025 SCHEDULE 13G/A Report for RECURSION PHARMACEUTICALS, INC. Class A Common Stock (RXRX)

Filing Manager: BAILLIE GIFFORD & CO
Reporting Manager: BAILLIE GIFFORD & CO
Security: RECURSION PHARMACEUTICALS, INC. Class A Common Stock
Symbol: RXRX
Shares outstanding: 516,847,217 shares
Disclosed Ownership: 23,774,972 shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Filing time: 05 Feb 2026, 10:04:18 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	4.6%	23,774,972	23,730,293	0	Grant Meikle	Regulatory Reporting Manager